CVS Health (CVS) Competitors

In the previous week, Walmart had 161 more articles in the media than CVS Health. MarketBeat recorded 227 mentions for Walmart and 66 mentions for CVS Health. CVS Health's average media sentiment score of 1.47 beat Walmart's score of 0.74 indicating that CVS Health is being referred to more favorably in the media.

CVS Health has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Walmart has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Walmart pays an annual dividend of $0.99 per share and has a dividend yield of 0.9%. CVS Health pays out 70.4% of its earnings in the form of a dividend. Walmart pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CVS Health has raised its dividend for 4 consecutive years and Walmart has raised its dividend for 53 consecutive years.

CVS Health presently has a consensus target price of $107.17, suggesting a potential upside of 13.74%. Walmart has a consensus target price of $131.88, suggesting a potential upside of 26.40%. Given Walmart's stronger consensus rating and higher possible upside, analysts plainly believe Walmart is more favorable than CVS Health.

Walmart has higher revenue and earnings than CVS Health. CVS Health is trading at a lower price-to-earnings ratio than Walmart, indicating that it is currently the more affordable of the two stocks.

80.7% of CVS Health shares are held by institutional investors. Comparatively, 26.8% of Walmart shares are held by institutional investors. 0.9% of CVS Health shares are held by insiders. Comparatively, 0.1% of Walmart shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Walmart has a net margin of 3.00% compared to CVS Health's net margin of 1.18%. Walmart's return on equity of 21.83% beat CVS Health's return on equity.

Cigna Group has a net margin of 2.27% compared to CVS Health's net margin of 1.18%. Cigna Group's return on equity of 19.75% beat CVS Health's return on equity.

In the previous week, CVS Health had 21 more articles in the media than Cigna Group. MarketBeat recorded 66 mentions for CVS Health and 45 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.49 beat CVS Health's score of 1.47 indicating that Cigna Group is being referred to more favorably in the news media.

Cigna Group has lower revenue, but higher earnings than CVS Health. Cigna Group is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CVS Health currently has a consensus price target of $107.17, indicating a potential upside of 13.74%. Cigna Group has a consensus price target of $339.45, indicating a potential upside of 20.80%. Given Cigna Group's higher possible upside, analysts plainly believe Cigna Group is more favorable than CVS Health.

CVS Health has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.29, indicating that its stock price is 71% less volatile than the broader market.

CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. CVS Health pays out 70.4% of its earnings in the form of a dividend. Cigna Group pays out 25.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CVS Health has raised its dividend for 4 consecutive years and Cigna Group has raised its dividend for 5 consecutive years.

80.7% of CVS Health shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.9% of CVS Health shares are owned by company insiders. Comparatively, 0.6% of Cigna Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Humana presently has a consensus target price of $403.91, indicating a potential upside of 3.55%. CVS Health has a consensus target price of $107.17, indicating a potential upside of 13.74%. Given CVS Health's stronger consensus rating and higher possible upside, analysts plainly believe CVS Health is more favorable than Humana.

CVS Health has a net margin of 1.18% compared to Humana's net margin of 0.88%. CVS Health's return on equity of 13.12% beat Humana's return on equity.

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Humana pays out 33.5% of its earnings in the form of a dividend. CVS Health pays out 70.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CVS Health has raised its dividend for 4 consecutive years. CVS Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, CVS Health had 31 more articles in the media than Humana. MarketBeat recorded 66 mentions for CVS Health and 35 mentions for Humana. CVS Health's average media sentiment score of 1.47 beat Humana's score of 1.29 indicating that CVS Health is being referred to more favorably in the news media.

CVS Health has higher revenue and earnings than Humana. CVS Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

92.4% of Humana shares are owned by institutional investors. Comparatively, 80.7% of CVS Health shares are owned by institutional investors. 0.2% of Humana shares are owned by insiders. Comparatively, 0.9% of CVS Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Humana has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market.

CVS Health has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Pfizer has a beta of 0.34, meaning that its share price is 66% less volatile than the broader market.

Pfizer has lower revenue, but higher earnings than CVS Health. CVS Health is trading at a lower price-to-earnings ratio than Pfizer, indicating that it is currently the more affordable of the two stocks.

CVS Health presently has a consensus price target of $107.17, indicating a potential upside of 13.74%. Pfizer has a consensus price target of $28.28, indicating a potential downside of 0.18%. Given CVS Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe CVS Health is more favorable than Pfizer.

CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Pfizer pays an annual dividend of $1.72 per share and has a dividend yield of 6.1%. CVS Health pays out 70.4% of its earnings in the form of a dividend. Pfizer pays out 226.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CVS Health has increased its dividend for 4 consecutive years and Pfizer has increased its dividend for 16 consecutive years. Pfizer is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Pfizer had 11 more articles in the media than CVS Health. MarketBeat recorded 77 mentions for Pfizer and 66 mentions for CVS Health. CVS Health's average media sentiment score of 1.47 beat Pfizer's score of 0.98 indicating that CVS Health is being referred to more favorably in the media.

80.7% of CVS Health shares are held by institutional investors. Comparatively, 68.4% of Pfizer shares are held by institutional investors. 0.9% of CVS Health shares are held by company insiders. Comparatively, 0.6% of Pfizer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Pfizer has a net margin of 6.80% compared to CVS Health's net margin of 1.18%. Pfizer's return on equity of 19.63% beat CVS Health's return on equity.